Arch Biopartners, Inc. (ARCH.V)
0.86
+0.03
(+3.61%)
CAD |
TSXV |
Oct 13, 16:00
Arch Biopartners Net Income (Quarterly) : -0.4751M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4751M |
| March 31, 2026 | -0.521M |
| December 31, 2025 | -1.559M |
| September 30, 2025 | -0.2698M |
| June 30, 2025 | -0.2423M |
| March 31, 2025 | -0.5516M |
| December 31, 2024 | -0.4163M |
| September 30, 2024 | -1.104M |
| June 30, 2024 | -0.8846M |
| March 31, 2024 | -1.148M |
| December 31, 2023 | -0.7832M |
| September 30, 2023 | 0.2443M |
| June 30, 2023 | -0.4508M |
| March 31, 2023 | -0.9624M |
| December 31, 2022 | -2.158M |
| September 30, 2022 | -0.498M |
| June 30, 2022 | -0.2474M |
| March 31, 2022 | -0.4877M |
| December 31, 2021 | -0.1748M |
| September 30, 2021 | 0.6531M |
| June 30, 2021 | 0.882M |
| March 31, 2021 | -1.052M |
| December 31, 2020 | -1.652M |
| September 30, 2020 | -1.61M |
| June 30, 2020 | -2.190M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0953M |
| December 31, 2019 | -0.733M |
| September 30, 2019 | -0.9739M |
| June 30, 2019 | -0.0516M |
| March 31, 2019 | -0.5137M |
| December 31, 2018 | -0.8183M |
| September 30, 2018 | -0.7862M |
| June 30, 2018 | -1.486M |
| March 31, 2018 | -0.5841M |
| December 31, 2017 | -0.3418M |
| September 30, 2017 | -0.2202M |
| June 30, 2017 | -1.306M |
| March 31, 2017 | -0.1543M |
| December 31, 2016 | -0.2354M |
| September 30, 2016 | -0.3448M |
| June 30, 2016 | -0.1828M |
| March 31, 2016 | -0.3229M |
| December 31, 2015 | -0.156M |
| September 30, 2015 | -0.1461M |
| June 30, 2015 | -0.1659M |
| March 31, 2015 | -0.1682M |
| December 31, 2014 | -0.3589M |
| September 30, 2014 | -0.1562M |
| June 30, 2014 | -0.1309M |
| March 31, 2014 | -0.0586M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Innovotech, Inc. | -0.6557M |
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.4751M |
| EPS Diluted (Quarterly) | -0.007 |
| Enterprise Value | 61.15M |
| Earnings Yield | -4.94% |
| Normalized Earnings Yield | -4.930 |